The modified Salmonella, was used against mouse models of EGFR-positive colon and breast cancer to effectively target the tumour microenvironment and selectively kill the EGFR-expressing tumour cells, inhibiting further tumour growth [132]. This evidence concerns the gene EGFR and breast cancer.